Chemical Engineer Wins CPRIT to Improve Effectiveness of Cancer Immunotherapy


(Patrick) #1

CPRIT awarded $1,173,420 to Navin Varadarajan, associate professor of chemical and biomolecular engineering, to improve the effectiveness of T-cell immunotherapy for cancer patients.

Varadarajan will use his grant to bring consistent results to cancer patients undergoing T-cell immunotherapy by manufacturing programmed T cells to meet, recognize and destroy tumors.

That’s what the immune systems’ T cells are for; by nature they fight invaders or infections.